BIONDVAX PHARMACEUTICALS LTD's ticker is and the CUSIP is 09073Q204. A total of 11 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 244,966 | $213,120 | 0.16% |
| ARMISTICE CAPITAL, LLC | 362,448 | $315,330 | 0.01% |
| UBS Group AG | 824 | $717 | 0.00% |
| RHUMBLINE ADVISERS | 3,549 | $3,084 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20 | $17 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 2,282 | $1,985 | 0.00% |
| Qube Research & Technologies Ltd | 7 | $6 | 0.00% |
| Global Retirement Partners, LLC | 50 | $38 | 0.00% |
| Aspire Private Capital, LLC | 160 | $139 | 0.00% |